“Moody’s Upgrades Flagstar Bank (NYSE:FLG) Following Financial Enhancement”
Moody's upgrades Flagstar Bank's credit rating, acknowledging its improved financial health and performance. The significant rise in the bank’s tangible common equity to risk-weighted assets ratio marks increased stability. Flagstar is now focusing on less risky C&I lending, further fortifying its portfolio against potential shocks. Read more
Read More
“Neurocrine Biosciences Adds $2.9B Soleno Therapeutics to Portfolio (NASDAQ:NBIX)”
With a bullish price target from Oppenheimer and a strategic acquisition of Soleno Therapeutics, Neurocrine Biosciences is poised for robust growth. The deal enhances Neurocrine's portfolio with Soleno's FDA-approved treatment, VYKAT XR, securing a more dominant stand in the endocrinology and rare disease markets. Read more
Read More
“Skillsoft’s Earnings Preview: Overcoming Financial Hurdles with AI Innovation”
Witness the AI-driven surge with Skillsoft's CAISY™ platform, outpacing user growth by 2.3 times with an impressive 146% YoY increase. However, despite this innovation excellence, Skillsoft faces financial hurdles that challenge its sustainability. Discover their strategy to address these challenges and maintain market presence with their upcoming business plan and earnings release. Read more
Read More